#分享美股交易赢英伟达股票

Today’s UnitedHealth stock market outlook

UnitedHealth opened strongly today, breaking through resistance; as of 10:30 AM Eastern Time, the stock price increased by +2.38%, trading at $528.60 (yesterday’s close was $516.30). Key driving factors include:

Policy favorable catalysts: The Biden administration expands Medicare Advantage coverage,预计新增 4 million users

Better-than-expected earnings: Optum health services division Q2 revenue up +18% YoY, AI diagnostic platform usage rate exceeds 60%

Accelerated buybacks: The board approved an additional $8 billion stock repurchase plan, with $4.2 billion repurchased this year

Technical indicator analysis

Trend and moving averages:

Stock price gap-up breakthrough of the $520 historical resistance, 5/10/50-day moving averages steeply rising at a 60-degree angle

200-day moving average ($505) slope accelerating upward, weekly upward channel opening

Momentum indicators:

RSI surges to 66: enters strong zone, volume supports effective breakout

MACD red bars surge: fast line crosses above slow line forming a "flying dragon in the sky" pattern, bullish momentum explodes

Volume-price structure:

One-hour opening volume of 3.8 million shares (exceeding monthly average by 45%)

In the $525–$528 range, institutional buying accounts for 85%

During trading, a large block trade of $210 million occurred at $527.5, indicating strong accumulation by major players

Key support and resistance levels

Support levels:

$525.20: gap-up upper edge + opening price resonance support

$520.00: breakout conversion point + 5-day moving average anchor

Resistance levels:

$532.80: year-to-date high (set in May 2026)

$538.00: previous all-time high + options gamma squeeze critical zone

Market outlook

Short-term (today):

Expected to directly attack the $530–$533 resistance zone, with core catalysts:

1:00 PM Senate healthcare hearing: If new telemedicine reimbursement rules pass, it will benefit an additional $1.5 billion in revenue

CPI data linkage: Cooling inflation will reduce medical claims cost pressure

Medium to long-term (1-3 months):

Clear growth engines:

✅ Digital healthcare explosion: FDA breakthrough certification for AI diagnostic tools, pre-installation fee of $50 per doctor per month

✅ Prescription drug cost control breakthrough: PBM bargaining power increases, drug costs decrease by 12%

⚠ Regulatory risks: Antitrust investigations may require splitting off Optum pharmacy business

Trading suggestions

Short-term traders:

Buy above $526, with stop-loss at $522.5 (exit if breaking below intraday moving average)

Add positions after breaking $532.8, target $535–$538 with tiered profit-taking

Long-term investors:

Deep moat of healthcare industry leaders, recommend pyramid layout:

Current price $528.6 (8%)

Pullback to $523 (5%)

Sharp decline to $515 (3%)